Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bayerische Motoren Werke ADR
(OP:
BMWYY
)
29.20
UNCHANGED
Last Price
Updated: 3:59 PM EDT, Sep 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bayerische Motoren Werke ADR
< Previous
1
2
3
4
5
6
7
8
9
...
65
66
Next >
IONCHI Welcomes AITO to Join Hands with BMW and Mercedes-Benz to Develop Premium High-Power Charging Networks in China
April 21, 2026
Via
Get News
Topics
Electric Vehicles
BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Biotech Valuation Trends
April 21, 2026
Via
Investor Brand Network
Topics
Intellectual Property
Why Molecular Testing is Increasingly Important in CNS Cancers
April 21, 2026
Via
Investor Brand Network
IONCHI Welcomes AITO to Join Hands with BMW and Mercedes-Benz to Develop Premium High-Power Charging Networks in China
April 21, 2026
Via
Press Release Distribution Service
Topics
Electric Vehicles
BMW of Cincinnati North Recognized in Best of Cincinnati 2026, Highlighting Excellence in Luxury Sales and Ownership Experience
April 21, 2026
Via
Press Release Distribution Service
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Reports Early Dosing Progress in Phase IIa Trial of Intranasal Concussion Therapy
April 20, 2026
Via
Investor Brand Network
BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Supports Executive Order To Accelerate Psychedelic Drug Development
April 20, 2026
Via
Investor Brand Network
When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech
April 20, 2026
Via
Investor Brand Network
Soligenix Inc. (NASDAQ: SNGX) Strengthens Pipeline as European Commission Grants SGX945 Orphan Status
April 17, 2026
Via
Investor Brand Network
Precision Oncology Is Shifting Toward Combination Strategies, Ultimately Changing How New Therapies Are Built
April 17, 2026
Via
Investor Brand Network
Nio Already Has a European Solution: Finally Time to Buy the Stock?
↗
April 17, 2026
One of Nio's biggest problems is premium brand sales growth in Europe, but it might already have a solution.
Via
The Motley Fool
Topics
Electric Vehicles
World Trade
Americans are Supplementing Healthcare Visits with AI, Gallup Survey Finds
April 17, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Soligenix Inc. (NASDAQ: SNGX) Advances CTCL Research with Interim Analysis, Comparative Study Results
April 16, 2026
Via
Investor Brand Network
New AI Tool Could Boost the Early Detection of Lung Cancer
April 16, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Oncotelic Therapeutics Inc. (OTLC) Expands Beyond Biotech Through AI-Robotics Pivot, Unlocking New Value in GMP Automation
April 16, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Hazel E Hosts Starline Tours Bus to Sonic Desert - A Launch to Coachella
April 15, 2026
Via
PRLog
BioMedNewsBreaks — MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Engages Venture Liquidity Providers for Market-Making Services
April 15, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Soligenix Inc. (NASDAQ: SNGX) Gains Analytical Validation as Pipeline Progress Drives Forward Outlook
April 15, 2026
Via
Investor Brand Network
Lucid Taps Industrial Heavyweight Silvio Napoli as CEO to Navigate High-Stakes Pivot
April 14, 2026
NEWARK, CA – In a decisive move to salvage its position in the increasingly crowded electric vehicle landscape, Lucid Group, Inc. (NASDAQ: LCID) announced today, April 14, 2026, the appointment of...
Via
MarketMinute
Topics
Economy
Electric Vehicles
Supply Chain
Lucid Group (LCID) Targets $1.05 Billion in New Financing to Scale EV Production and Robotaxi Efforts
April 14, 2026
In a decisive move to secure its long-term viability and pivot toward mass-market appeal, Lucid Group (NASDAQ: LCID) announced today, April 14, 2026, a comprehensive $1.05 billion strategic financing...
Via
MarketMinute
Topics
Electric Vehicles
Cautious Optimism Surrounds BMW’s Announcement of New Hydrogen SUV
April 14, 2026
Via
Investor Brand Network
Preclinical Study Reveals Promising Treatment for Glioblastoma
April 14, 2026
Via
Investor Brand Network
Lucid at a Crossroads: Efficiency, Scale, and the $1 Billion Saudi Lifeline of 2026
April 14, 2026
Today, April 14, 2026, Lucid Group, Inc. (NASDAQ: LCID) finds itself at a defining moment in its decade-plus journey. Once hailed as the "Tesla-killer" during the luxury EV euphoria of the early 2020s,...
Via
Finterra
Topics
Economy
Supply Chain
The Power Architect: A Deep Dive into onsemi’s (ON) Strategic Transformation and SiC Leadership
April 13, 2026
As of April 13, 2026, the semiconductor landscape has transitioned from a period of "scarcity at any cost" to a sophisticated battle for efficiency and vertical integration. At the heart of this...
Via
Finterra
Topics
Artificial Intelligence
Economy
Electric Vehicles
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Offers World’s First Voice-Enabled AI-Powered Drug and Alcohol Platform for Workplace Substance Abuse Screening
April 13, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
BioMedNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Doses First Patient in Phase IIa Trial of Concussion Treatment
April 13, 2026
Via
Investor Brand Network
Motor Works Fills the Dealership Void in DeKalb with Factory-Level Diagnostics and a “Heart of a Teacher”
April 10, 2026
Via
Get News
Why Ford's Q1 Will Be Less Lucrative Than Its Crosstown Rival's
↗
April 10, 2026
First-quarter sales for U.S. automakers were rough, but Ford had one significant decline that could be costly.
Via
The Motley Fool
Topics
Energy
Supply Chain
World Trade
Stellantis Shines in Q1, Giving Investors an Opportunity for Big Turnaround Gains
↗
April 10, 2026
After seven years of annual sales declines, Stellantis investors are desperate for sales to gain traction and drive results higher. Here's the good news.
Via
The Motley Fool
Topics
World Trade
Immunotherapy Could Be Boosted by Blocking the Removal of Cancer RNA
April 10, 2026
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
8
9
...
65
66
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.